ArticleThe Pan African medical journal2025
Community awareness and neuroepidemiology of onchocerciasis-associated epilepsy in two rural communities in Cameroon.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Community-directed treatment with ivermectin in Maridi, South Sudan: Impact of an onchocerciasis awareness campaign and bi-annual treatment on therapeutic coverage.PLoS neglected tropical diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: onchocerciasis is the leading cause of epilepsy in onchocerciasis-endemic communities. Our study aimed to determine the incidence, prevalence and community awareness of Onchocerciasis-associated epilepsy (OAE) in two onchocerciasis-endemic rural communities in Cameroon. Methods: we conducted a community-based cross-sectional study in two rural villages (Yangafock I, and Yangafock II) in the Mbam et Kim division of the Center Region of Cameroon. Door-to-door household visits were conducted to screen for individuals with epilepsy. OAE was defined using previously established criteria. Using an established questionnaire, we assessed community awareness of OAE. Results: seven hundred and ninety-nine (799) peoples from 102 households (380 in Yangafock I and 419 in Yangafock II) were screened. Fifty-three (53) peoples, (33 from Yangafock I and 20 from Yangafock II) met the OAE clinical criteria. Two hundred and forty-nine (249) persons completed the community awareness questionnaire. For Yangafock I, the overall prevalence of epilepsy was 78.75 per 1000, while for Yangafock II, it was 47.7 per 1000. The five-year incidence of epilepsy was 23.8 per 1000 and 11.9 per 1000 for 44 Yangafock I and Yangafock II, respectively. The most affected age group was 20-29 years. Community members had a critically low level of OAE awareness and risk perception. Conclusion: the high prevalence and a critically low level of public awareness underscore the need to raise community awareness of OAE to increase community engagement in the fight against onchocerciasis and its complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.